Summary
We investigated the interaction of endogenous interleukin (IL)-1β, IL-1ra, and interleukin-1β converting enzyme (ICE) in four human urological cancer cell lines, KU-19-19, KU-1, KU-2 and KU-19-20. Northern blot analysis showed that IL-1β gene was expressed in all cell lines. On the other hand, in KU-19-19 and KU-19-20, the gene expressions of both IL-1ra and ICE were suppressed. MTT assay revealed that IL-1β (10 ng ml–1) promoted cell growth in KU-19-19 and KU-19-20, while it inhibited in KU-1 and KU-2. An ICE inhibitor, Acetyl-Tyr-Val-Ala-Asp-CHO (YVAD-CHO) blocked IL-1β-induced growth inhibition in KU-1 and KU-2. Overexpression of the secretory type IL-1ra with adenovirus vector (AxIL-1ra) enhanced ICE gene expression, while exogenous IL-1ra (100 ng ml–1) did not enhance it. Furthermore, AxIL-1ra treatment promoted endogenous IL-1β secretion and induced significant growth inhibition and apoptotic cell death on KU-19-19 and KU-19-20. Treatment with either IL-1ra (100 ng ml–1), IL-1β antibody (100 μg ml–1), or YVAD-CHO blocked AxIL-1ra-induced cell death in KU-19-19 and KU-19-20. These results suggest that IL-1β-sensitivity depends on the level of ICE gene expression, which is regulated by the level of endogenous sIL-1ra expression. This is a first report on the intracellular function of sIL-1ra and these findings may provide key insights into the mechanism underlying the viability of cancer cells.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alnemri, ES, Livingston, DJ, Nicholson, DW, Salvesen, G, Thornberry, NA, Wong, WW & Yuan, J (1996). Human ICE/CD-3 protease nomenclature [letter]. Cell 87: 171
Araki, M, Yano, T, Hayashi, H, Takii, T, Suzuki, K & Onozaki, K (1994). Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6. Int J Cancer 56: 275–280.
Arend, WP, Welgus, HG, Thompson, RC & Eisenberg, SP (1990). Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 85: 1694
Black, RA, Kronheim, SR & Sleath, PR (1989). Activation of interleukin-1 beta by a co-induced protease. FEBS Lett 247: 386–390.
Cerretti, DP, Kozlosky, CJ, Mosley, B, Nelson, N, Van, NK & Greenstreet, TA (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97–100.
Corradi, A, Franzi, AT & Rubartelli, A (1995). Synthesis and secretion of interleukin-1α and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes. Exp Cell Res 217: 355–362.
Dinarello, CA (1996). Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.
Dinarello, CA & Thompson, RC (1991). Blocking IL-1:IL-1RA in vivo and in vitro. Immunol Today 12: 404–410.
Dinarello, CA & Wolff, SM (1993). The role of interleukin-1 disease. N Engl J Med 328: 106–113.
Enari, M, Talanian, RV, Wong, WW & Nagata, S (1996). Sequential activation of ICE-like and CPP-like proteases during Fas-mediated apoptosis. Nature 380: 723–726.
Fratelli, M, Gagliardini, V, Galli, G, Gnocchi, P, Ghiara, P & Ghezzi, P (1995). Autocrine interleukin-1β regulates both proliferation and apoptosis in EL4-6.1 thymoma cells. Blood 85: 3532–3537.
Freedman, AS, Freeman, G, Whitman, J, Sejil, J, Dley, J & Nadler, LM (1988). Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. J Immunol 141: 3398–3404.
Friedlander, RM, Gagliardini, V, Rotello, RJ & Yuan, J (1996). Functional role of interleukin 1β-converting enzyme-mediated apoptosis. J Exp Med 184: 717–724.
Furukawa, Y, Kikuchi, J, Terui, Y, Kitagawa, S, Ohta, M, Miura, Y & Saito, M (1995). Preferential production of interleukin-1β over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemia cells. Jpn J Cancer Res 86: 208–216.
Gaffney, EV & Tsai, SC (1986). Lymphocyte-activating and growth-inhibitory activities for several sources native and recombinant interleukin 1. Cancer Res 46: 3834–3837.
Gery, I, Gershon, RK & Waksman, BH (1972). Potentiation of the T-lymphocyte responce to mitogens. I. The responding cell. J Exp Med 136: 128–142.
Goletti, D, Kinter, AL, Hardy, EC, Poli, G & Fauci, AS (1996). Modulation of endogenous IL-1β and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J Immunol 156: 3501–3508.
Grassi, J, Roberge, CJ, Frobert, Y, Pradelles, P & Poubelle, PE (1991). Determination of IL-1α, IL-1β, and IL-2 in biological media using specific enzyme immunometric assays. Immunol Rev 119: 125–145.
Hazuda, DJ, Lee, JC & Young, PR (1988). The kinetics of interleukin 1 secretion from activated monocytes. J Biol Chem 263: 8473–8479.
Hogquist, AH, Nett, MA, Unanue, ER & Chaplin, DD (1991). Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88: 8485–8489.
Ito, R, Kitadai, Y, Kyo, E, Yokozaki, H, Yasui, W, Yamashita, U, Nikai, H & Tahara, E (1993). Interleukin-1α acts as autocrine growth stimulator for human gastric carcinoma cells. Cancer Res 53: 4102–4106.
Kanegae, Y, Makimura, M & Saito, I (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47: 157–166.
Kanegae, Y, Lee, G, Sato, Y, Tanaka, M, Nakai, M, Sakaki, T, Sugano, S & Saito, I (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23: 3816–3821.
Katsuoka, Y, Baba, S, Hata, M & Tazaki, H (1976). Transplantation of human renal cell carcinoma to the nude mouse: as an intermediate of in vivo and in vitro studies. J Urol 115: 373–376.
Kostura, MJ, Tocci, MJ, Limjuco, G, Chin, J, Cameron, P & Hillman, AG (1989). Identification of a monocyte specific pre-interleukin-1 beta convertase. Proc Natl Acad Sci USA 86: 5227–5231.
Lachman, LB, Brown, DC & Dinarello, CA (1987). Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. J Immunol 138: 2913–2916.
Lonnenmann, G, Endras, S, Van der Meer, JW, Cannon, JG, Koch, KM & Dinarello, CA (1989). Differences in the synthesis and kinetics of release of interleukin-1. Eur J Immunol 19: 1531–1536.
Maier, JAM, Voulalas, P, Roeder, D & Maciag, T (1990). Extension of the life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249: 1570–1574.
Miura, M, Zhu, H, Rottelo, R, Hartweig, E & Yuan, J (1993). Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 641–652.
Miura, M, Friedlander, RM & Yuan, J (1995). Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 92: 8318–8322.
Miyake, S, Makimura, M, Kanegae, Y, Harada, S, Sato, Y, Takamori, K, Tokuda, C & Saito, I (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93: 1320–1324.
Oelmann, E, Kraemer, A, Serve, H, Reufi, B, Oberberg, D, Patt, S, Herbst, H, Stein, H, Thiel, E & Berdel, WE (1997). Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Int J Cancer 71: 1066–1076.
Onozaki, K, Matsushima, K, Aggarwal, BB & Oppenheim, JJ (1985). Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135: 3962–3968.
Oppenheim, JJ, Kovacs, EJ, Matsushima, K & Durum, SK (1986). There is more than one interleukin-1. Immunol Today 7: 45–56.
Schmidt, JA, Mizel, SB, Cohen, D & Green, I (1982). Interleukin-1, a potent regulator of fibroblast proliferation. J Immunol 128: 2177–2182.
Smith, DJ, McGuire, MJ, Tocci, MJ & Thiele, DL (1997). IL-1β converting enzyme (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J Immunol 158: 163–170.
Tachibana, M (1982). Studies on cellular adhesiveness in five different culture cell lines derived from carcinoma of the urinary bladder. Keio J Med 31: 127–148.
Tachibana, M, Miyakawa, A, Tazaki, H, Nakamura, K, Kubo, A, Hata, J, Nishi, T & Amano, Y (1995). Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55: 3438–3443.
Tachibana, M, Miyakawa, A, Nakashima, J, Murai, M, Nakamura, K, Kubo, A & Hata, J-I (1997a). Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. Br J Cancer 76: 163–174.
Tachibana, M, Miyakawa, A, Uchida, A, Murai, M, Eguchi, K, Nakamura, K, Kubo, A & Hata, J-I (1997b). Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder. Br J Cancer 75: 1489–1496.
Tatsuda, T, Cheng, J & Mountz, JD (1996). Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis. J Immunol 157: 3949–3957.
Zychlinsky, A, Fitting, C, Cavaillon, JM & Sansonetti, PJ (1994). Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest 94: 1328–1332.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sumitomo, M., Tachibana, M., Murai, M. et al. Overexpression of IL-1ra gene up-regulates interleukin-1β converting enzyme (ICE) gene expression: Possible mechanism underlying IL-1β-resistance of cancer cells. Br J Cancer 81, 277–286 (1999). https://doi.org/10.1038/sj.bjc.6690688
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690688
Keywords
This article is cited by
-
Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines
British Journal of Cancer (2003)